Our clinical trials registry and results.
We publically release clinical study information in accordance with all applicable national laws and rules governing personal data privacy and the protection of intellectual property rights.
We make sure that all information about clinical studies is easily accessible by publishing it on recognised public databases such as Clinicaltrials.gov in the USA, & EudraCT in the European Union (EU).
Click the link below for an overview of the registration and results of our ongoing clinical trials:
Our transparency policy.
We work towards better healthcare for all through transparency and openness. Our transparency policy follows the recommendation of the Association of British Pharmaceutical Industry (ABPI) and as well as the European Federation of Pharmaceutical Industries & Associations (EFPIA) / Pharmaceutical Research & Manufacturers of America (PhRMA) Joint Position Papers on the Disclosure of Clinical Trial Information via Clinical Trials Registries & Databases and the Principles for Responsible Clinical Trial Data Sharing.
We are committed to implementing processes and systems that facilitate any study data request submitted on or after January 2014 by qualified scientific or medical researchers, for medicines and indications approved in the USA and the EU on or after January 2014.
To facilitate clinical study data sharing in line with our Transparency Policy, researchers can submit a request by sending a proposal here. All requests will be evaluated independently on a case-by-case.
We are committed to carrying out our global clinical trials efficiently in terms of time and quality, in line with internationally-accepted scientific and ethical standards. Clinical trials are performed according to the requirements of the authorities in the countries where the trials are performed and following European Directives & Guidelines, such as Good Clinical Practice from the International Conference of Harmonisation, as well as FDA GCP regulations contained in Code 21 of Federal Regulations, or other international requirements.
Please keep in mind that the information on this web is not intended to replace advice from healthcare professionals. Patients should always seek medical advice before starting or changing their treatment. Healthcare professionals should consult the approved labelling for the patient's country to ensure that they receive the most up-to-date and appropriate information according to local requirements.